[1]
Yalçın, C. et al. 2022. EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric glycopeptide use in neutropenic fever. Mediterranean Journal of Hematology and Infectious Diseases. 14, 1 (Apr. 2022), e2022039. DOI:https://doi.org/10.4084/MJHID.2022.039.